Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOSE-3
2024-513489-20-00Phase 3Authorised
- Sponsor
- Laboratorios Salvat
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of clobetasol in Postoperative ocular inflammation (2 arms), sponsored by Laboratorios Salvat. Planned start Jun 2024; status: authorised.
02
Drugs
clobetasol
03
Conditions
Postoperative ocular inflammation
Beyond the preview
Go deeper on 2024-513489-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513489-20-00.